Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dar El Oyoun Hospital is a leading specialized ophthalmology healthcare provider based in Egypt, with a significant presence across the Middle East. Founded in 1995 by Professor Dr. Khalil El-Deeb, the hospital group offers a comprehensive range of eye care services, including LASIK, cataract surgery, glaucoma treatment, and retinal procedures. It operates a network of specialized centers equipped with advanced diagnostic and surgical technologies such as Femto-LASIK and phacoemulsification. The company focuses on providing high-quality ophthalmic care through a team of expert consultants and state-of-the-art facilities. In 2020, the private equity firm SPE Capital acquired a majority stake in the group to facilitate regional expansion and modernize its service offerings. Today, Dar El Oyoun is recognized as one of the largest and most prestigious eye care networks in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dar El Oyoun Hospital.